149 related articles for article (PubMed ID: 8793372)
21. [Exacerbation of psoriasis during treatment with H2 antagonists].
Andersen M
Ugeskr Laeger; 1991 Jan; 153(2):132. PubMed ID: 1671185
[No Abstract] [Full Text] [Related]
22. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
Iwagami M; Kumazawa R; Miyamoto Y; Ito Y; Ishimaru M; Morita K; Hamada S; Tamiya N; Yasunaga H
Drug Saf; 2021 Mar; 44(3):361-371. PubMed ID: 33247391
[TBL] [Abstract][Full Text] [Related]
23. Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
Rampello L; Raffaele R; Nicoletti G; Le Pira F; Vecchio I; Malaguarnera M; Drago F
Clin Neuropharmacol; 1997 Feb; 20(1):49-54. PubMed ID: 9037573
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
25. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia].
Rampello L; Nicoletti G
Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922
[TBL] [Abstract][Full Text] [Related]
26. Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.
Cotton RB; Shah LP; Poole SD; Ehinger NJ; Brown N; Shelton EL; Slaughter JC; Baldwin HS; Paria BC; Reese J
J Mol Cell Cardiol; 2013 Jun; 59():86-94. PubMed ID: 23454087
[TBL] [Abstract][Full Text] [Related]
27. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
Koren G; Zemlickis DM
Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
[TBL] [Abstract][Full Text] [Related]
28. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
29. [H2 antagonists and the heart].
Corradini P; Zocchi M; Buonavia A
Minerva Med; 1986 Dec; 77(47-48):2209-15. PubMed ID: 2880317
[TBL] [Abstract][Full Text] [Related]
30. Famotidine and ranitidine, but not cimetidine, cause severe, disabling headache.
Hirsch E
Am J Gastroenterol; 1989 Feb; 84(2):202-3. PubMed ID: 2563629
[No Abstract] [Full Text] [Related]
31. Inhibition of acid and gastric carcinoids.
Elder JB
Gut; 1985 Dec; 26(12):1279-83. PubMed ID: 2867953
[No Abstract] [Full Text] [Related]
32. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
Møller H; Nissen A; Mosbech J
Gut; 1992 Sep; 33(9):1166-9. PubMed ID: 1358764
[TBL] [Abstract][Full Text] [Related]
33. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
[TBL] [Abstract][Full Text] [Related]
34. [Adverse effects of H2 blockaders].
Arabehety AR
Acta Gastroenterol Latinoam; 1980; 10(4):317-23. PubMed ID: 6115533
[No Abstract] [Full Text] [Related]
35. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
Purkins L; Wood N; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414
[TBL] [Abstract][Full Text] [Related]
36. Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cells.
Hahm KB; Lee SI; Chung JP; Kim WH; Kim JH; Park IS
Int J Immunopharmacol; 1994 Dec; 16(12):985-93. PubMed ID: 7705971
[TBL] [Abstract][Full Text] [Related]
37. Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer.
Coogan PF; Zhang Y; Palmer JR; Strom BL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1012-5. PubMed ID: 15824181
[TBL] [Abstract][Full Text] [Related]
38. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
39. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular adverse effects of H2-receptor antagonists].
Hinrichsen H; Kirch W
Dtsch Med Wochenschr; 1994 Apr; 119(14):525-30. PubMed ID: 7908870
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
